Michelle Renee Griffin, Director at Adaptive Biotechnologies Corp (ADPT), sold 14,916 shares at $35.00 ($522K) on 2021-08-27, disclosed to the SEC on 2021-08-30.
Open-market sale of $522k ADPT by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| ADPT | SELL | 2026-03-05 | $735K | — | Filing → |
| ADPT | SELL | 2025-03-17 | $522K | — | Filing → |
| ADPT | SELL | 2025-03-06 | $249K | — | Filing → |